SciELO - Scientific Electronic Library Online

 
vol.136 número9Impacto de la trombolisis y de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

KAUFFMANN Q, Ronald. Timing is crucial in acute myocardial infarction. Rev. méd. Chile [online]. 2008, vol.136, n.9, pp.1095-1097. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872008000900001.

Thrombolytic agents and primary angioplasty (ACP) are two well defined methods for the treatment of patients with ST segment elevation myocardial infarction (STEMI). The use of both methods consecutively, called facilitated angioplasty, is a third alternative, that offers few advantages and is restricted to a small group of patients. The experience abroad demonstrated that ACP offers a higher reduction in mortality than thrombolysis. This is also the case in a national repon published in this issue, showing that hospital mortality of patients treated with thrombolysis and ACP was 10.5% and 5.6%, respectively (p <0.01). The figures for long term mortality were 20.4% and 9.7%, respectively (p <0.01). The crucial factor to improve the treatment results in myocardial infarction in to reduce the time of total ischemia, from the onset ofsymptoms to the start of reperfusion therapy Nowadays, the therapeutic challenges, besides improving percutaneous and pharmacological interventions, are to achieve an early consultation and to reduce institutional timing.

Palabras clave : Angioplasty; Myocardial infarction; Thrombolytic therapy.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons